Sort   by:  
 Page size 
UnknownClinical pharmacology of cytotoxic drugs in neonates and infants: Providing evidence-based dosing guidance.
Not available
S-EPMC8914347 | biostudies-literature
UnknownDifferentiation of Human Embryonic Stem Cells to Sympathetic Neurons: A Potential Model for Understanding Neuroblastoma Pathogenesis.
Not available
S-EPMC6236576 | biostudies-literature
UnknownLoss of ALK hotspot mutations in relapsed neuroblastoma.
Not available
S-EPMC9826054 | biostudies-literature
UnknownIncreased Replication Stress Determines ATR Inhibitor Sensitivity in Neuroblastoma Cells.
Not available
S-EPMC8699051 | biostudies-literature
UnknownExperimental Cancer Medicine Centre (ECMC) network proposal for a consensus gene panel for pan-cancer sequencing: a Delphi methodology.
Not available
S-EPMC12820137 | biostudies-literature
UnknownCombination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models.
Not available
S-EPMC10068437 | biostudies-literature
UnknownFrontline and Relapsed Rhabdomyosarcoma (FAR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).
Not available
S-EPMC10931395 | biostudies-literature
UnknownAge Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group.
Not available
S-EPMC7605396 | biostudies-literature
UnknownFrequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1).
Not available
S-EPMC8791815 | biostudies-literature
UnknownStratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States.
Not available
S-EPMC11962403 | biostudies-literature
Sort   by:  
 Page size